Immuneering Corp (IMRX)

Finanzdaten der Immuneering Corp-Aktie (IMRX)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	5.99% 15.33	16.30	13.93	13.50	14.68
Operating Income/Loss	5.99% -15.33	-16.30	-13.93	-13.50	-14.68
Income/Loss From Continuing Operations Before Tax	5.14% -14.31	-15.08	-12.60	-12.19	-13.60
Income/Loss From Continuing Operations After Tax	5.14% -14.31	-15.08	-12.60	-12.19	-13.60
Net Income/Loss	5.14% -14.31	-15.08	-12.60	-12.19	-13.60
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	10,114% 29.37	0.2876	29.27	28.65	26.44
Diluted Average Shares	10,114% 29.37	0.2876	29.27	28.65	26.44
Basic Earnings Per Share	5.77% -0.49	-0.52	-0.43	-0.43	-0.51
Diluted Earnings Per Share	5.77% -0.49	-0.52	-0.43	-0.43	-0.51
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-